Lymphocyte Inhibition Mechanisms and Immune Checkpoints in COVID-19: Insights into Prognostic Markers and Disease Severity
<i>Background and Objectives</i>: Immune checkpoint inhibitors such as PD-1 and TIM-3 play an important role in regulating the host immune response and are proposed as potential prognostic markers and therapeutic targets in severe cases of COVID-19. We evaluated the expression of PD-1 an...
Saved in:
| Main Authors: | Martina Schniederova, Anna Bobcakova, Marian Grendar, Adam Markocsy, Andrej Ceres, Michal Cibulka, Dusan Dobrota, Milos Jesenak |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2025-01-01
|
| Series: | Medicina |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1648-9144/61/2/189 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting the Efficacy of Immune Checkpoint Inhibitors in Esophageal Cancer: Changes in Peripheral Blood Lymphocyte Subsets Before and After Immunotherapy
by: Cao R, et al.
Published: (2025-04-01) -
Expression of immune checkpoint markers in peripheral blood lymphocytes of women with fibroadenoma of the breast
by: O. V. Kurmyshkina, et al.
Published: (2024-09-01) -
Predictors of severity and onset timing of immune-related adverse events in cancer patients receiving immune checkpoint inhibitors: a retrospective analysis
by: Qimei Fang, et al.
Published: (2025-02-01) -
Immunohistochemical Profiling of Immune Checkpoints in Chronic Hepatitis B Liver Tissue
by: João Panão-Costa, et al.
Published: (2025-06-01) -
Comparison of the diagnostic and prognostic value of criteria for immune checkpoint inhibitor related myocarditis
by: Milagros Pereyra Pietri, et al.
Published: (2025-03-01)